Please wait ...

Constantin Von der Groeben, Managing Director

Demecan


Dr. Constantin von der Groeben is a co-founder and managing director of DEMECAN. He leads the company’s legal and regulatory affairs department. Under his direction, DEMECAN won Germany’s tender process on cannabis cultivation licenses. Dr. von der Groeben’s expertise lies in the regulatory framework of medicinal cannabis including EU-GMP, narcotics, and pharmaceutical law. He believes that smart regulation of medicinal cannabis will allow for the development of a genuine pharmaceutical product that will be widely accepted by doctors, patients, and society as a whole.

Profile of current company

DEMECAN is the only German vertically integrated medicinal cannabis company. As a pharmaceutical producer and wholesaler DEMECAN covers the full supply and value chain of medicinal cannabis - from cultivation, processing and storage to distribution to pharmacies. As a company DEMECAN is committed to sufficiently supply patients in Germany with high-quality pharma-grade medicinal cannabis.
The company was founded in 2017 by Dr. Adrian Fischer (physician), Dr. Cornelius Maurer (economist) and Dr. Constantin von der Groeben.  DEMECAN is one of only three companies to be awarded a cultivation license in Germany.
DEMECAN is headquartered in Berlin and owns the largest cannabis indoor cultivation facility in Europe, which is located in eastern Germany.

Career info and accomplishments prior to the cannabis industry

Prior to committing his career to DEMECAN Dr. Constantin von der Groeben worked for several years as a corporate lawyer for top-tier law firms in Berlin, London and New York. He combines outstanding expertise in the public sector with in-depth knowledge of the cannabis industry and its specific requirements. In his previous roles, he served as a legal advisor to the Federal Ministry of Economic Affairs and Energy in Germany where he oversaw the management of government holdings. He also served as the personal assistant to Dr. Frank-Walter Steinmeier, the current President of Germany. Dr. von der Groeben holds a Ph.D. from the University of Cologne, and an LLM from New York University.

Product Type
On Demand

Defining Access: Medical, Adult, OTC, or Something Else?


Credit available - Click Here for more information

Average Rating:
Not yet rated
Category:
Cross Border Markets & Commerce |  Regulatory |  Licensing and Permitting |  Medical/Healthcare/Access |  Policy
Faculty:
David Mangone |  Rob Bonta |  Constantin Von der Groeben, Managing Director |  Deepak Anand
Duration:
1 Hour 4 Minutes
Format:
Audio and Video
License:
Access for 6 month(s) after purchase.
Short Description:
Join us for a discussion on what meaningful access means now and into the future.
Price:
$75.00 - Non Member Price

Showing 1 to 1 of 1 entries